Cargando…
Master Protocol Trial Design for Efficient and Rational Evaluation of Novel Therapeutic Oncology Devices
Historically, the gold standard for evaluation of cancer therapeutics, including medical devices, has been the randomized clinical trial. Although high-quality clinical data are essential for safe and judicious use of therapeutic oncology devices, class II devices require only preclinical data for U...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073911/ https://www.ncbi.nlm.nih.gov/pubmed/31504680 http://dx.doi.org/10.1093/jnci/djz167 |